Cost-effectiveness analysis of HLA-B*5701 typing in the prevention of hypersensitivity to abacavir in HIV+ patients in Spain.

Source:http://linkedlifedata.com/resource/pubmed/id/20144493

Download in:

View as

General Info

PMID
20144493